FDA Approves Ortho Dermatologics' Labeling for Jublia (efinaconazole) Topical Solution, 10%, In Patients As Young As Six Years Old

FDA News, New FDA Approvals
April 29, 2020
A+ A-
Email Print

Article Link: FDA Approves Ortho Dermatologics’ Labeling for Jublia (efinaconazole) Topical Solution, 10%, In Patients As Young As Six Years Old

LAVAL, Quebec, April 29, 2020 /PRNewswire/ — Bausch Health Companies Inc. (NYSE/TSX: BHC) and its dermatology business, Ortho Dermatologics, one of the largest prescription dermatology health care businesses, today announced the U.S. Food and Drug…

Source: FDA New Drug Approvals

Posted by

Newer Post
Older Post